Chemoinformaics analysis of Norxanthantolide A
Molecular Weight | 194.23 | nRot | 0 |
Heavy Atom Molecular Weight | 180.118 | nRig | 12 |
Exact Molecular Weight | 194.094 | nRing | 2 |
Solubility: LogS | -1.649 | nHRing | 1 |
Solubility: LogP | 1.575 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 30.1111 |
nHD | 0 | BPOL | 17.5169 |
QED | 0.642 |
Synth | 3.841 |
Natural Product Likeliness | 1.062 |
NR-PPAR-gamma | 0.138 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.008 |
HIA | 0.006 |
CACO-2 | -4.631 |
MDCK | 0.0000239 |
BBB | 0.307 |
PPB | 0.942722 |
VDSS | 0.632 |
FU | 0.0770942 |
CYP1A2-inh | 0.122 |
CYP1A2-sub | 0.8 |
CYP2c19-inh | 0.022 |
CYP2c19-sub | 0.55 |
CYP2c9-inh | 0.034 |
CYP2c9-sub | 0.861 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.854 |
CYP3a4-inh | 0.011 |
CYP3a4-sub | 0.206 |
CL | 15.836 |
T12 | 0.895 |
hERG | 0.003 |
Ames | 0.017 |
ROA | 0.155 |
SkinSen | 0.285 |
Carcinogencity | 0.827 |
EI | 0.032 |
Respiratory | 0.25 |
NR-Aromatase | 0.617 |
Antiviral | No |
Prediction | 0.707684 |